Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is challenging to treat due to a lack of guidance for clinicians. The daptomycin and ceftaroline combination is promising for treating persistent MRSA bloodstream infections (BSIs). In this report, we present a case series of 7 patients who failed vancomycin and then were treated with daptomycin and ceftaroline for persistent MRSA BSIs. The median age (IQR) of the included patients was 59 (48–67), with 5 male and 2 female patients. Six patients (85.7%) had a clinical cure for their persistent BSIs. The median time (IQR) for sterilization of MRSA BSIs after initiation of daptomycin and ceftaroline combination was 2 days (1–3). Among the patients who had clinical cures, the median time for clinical cures (IQR) was 6 weeks (4.5–6 weeks). The combination of daptomycin and ceftaroline could be an excellent treatment option for persistent MRSA BSIs.
Acknowledgment
We would like to thank Fadi Shehadeh, Infectious Diseases Division, Brown University, Rhode Island, United States, for identifying the patients from the electronic health record on daptomycin and ceftaroline.
Authors’ contributions
Y.S.A.: conceptualization, methodology, formal analysis, data curation, original draft preparation, writing, and editing. AAA: concept, methodology, formal analysis, and editing. TAA: conceptualization, methodology, and editing.
Authorship statement
We confirm that all authors meet the ICMJE and Taylor & Francis authorship criteria.
Data availability statement
Data are available upon request.
Disclosure statement
No potential conflict of interest was reported by the author(s).